These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1514176)

  • 21. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical application of a functional assay for protein C.
    Triplett DA; Sandquist DS; Musgrave KA
    Hematol Pathol; 1987; 1(4):239-47. PubMed ID: 3143709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases.
    Bertram B; Remky A; Arend O; Wolf S; Reim M
    Ger J Ophthalmol; 1995 Nov; 4(6):332-5. PubMed ID: 8751097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombin III, protein C, and protein S. Naturally occurring anticoagulant proteins.
    High KA
    Arch Pathol Lab Med; 1988 Jan; 112(1):28-36. PubMed ID: 2962557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary protein S deficiency in young adults with arterial occlusive disease.
    Allaart CF; Aronson DC; Ruys T; Rosendaal FR; van Bockel JH; Bertina RM; Briët E
    Thromb Haemost; 1990 Oct; 64(2):206-10. PubMed ID: 2148653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary protein S deficiency and venous thrombo-embolism. A study in three Dutch families.
    Broekmans AW; Bertina RM; Reinalda-Poot J; Engesser L; Muller HP; Leeuw JA; Michiels JJ; Brommer EJ; Briët E
    Thromb Haemost; 1985 Apr; 53(2):273-7. PubMed ID: 3161207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.
    Gschwandtner ME; Eichinger S; Hütter D; Korninger L; Lechner K; Panzer S; Pabinger I
    Blood Coagul Fibrinolysis; 1996 Apr; 7(3):325-30. PubMed ID: 8735139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence of hypercoagulation conditions in patients with thrombosis in Northern Navarra].
    Benedicto Aguirre E; Yuste JR; Páramo JA; Rocha E; Prieto J
    An Med Interna; 1997 Sep; 14(9):450-4. PubMed ID: 9453752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of hemostasis in patients with a recent thromboembolic complication].
    Samama MM
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11 Suppl):1793-7. PubMed ID: 8815842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study.
    Pabinger I; Kyrle PA; Heistinger M; Eichinger S; Wittmann E; Lechner K
    Thromb Haemost; 1994 Apr; 71(4):441-5. PubMed ID: 8052960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S.
    Finazzi G; Barbui T
    Thromb Haemost; 1994 Jan; 71(1):15-8. PubMed ID: 8165635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women.
    Folkeringa N; Brouwer JL; Korteweg FJ; Veeger NJ; Erwich JJ; Holm JP; van der Meer J
    Br J Haematol; 2007 Feb; 136(4):656-61. PubMed ID: 17223916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease.
    Glueck CJ; Glueck HI; Greenfield D; Freiberg R; Kahn A; Hamer T; Stroop D; Tracy T
    Pediatr Res; 1994 Apr; 35(4 Pt 1):383-8. PubMed ID: 8047373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural and acquired inhibitors of hemostasis in selected symptomatic outpatients with venous thromboembolic disease.
    Bazzan M; Tamponi G; Vaccarino A; Montaruli B; Aluffi E; Schinco P; Pannocchia A; Borchiellini A; Rabbia C; Pileri A
    Haematologica; 1997; 82(4):420-2. PubMed ID: 9299854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory screening of inherited thrombotic syndromes.
    Mannucci PM; Tripodi A
    Thromb Haemost; 1987 Jun; 57(3):247-51. PubMed ID: 3116699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease.
    Mader R; Ziv M; Adawi M; Mader R; Lavi I
    J Rheumatol; 1999 Nov; 26(11):2404-8. PubMed ID: 10555901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].
    Sokołowska B; Piecuch W; Walter-Croneck A; Dmoszyńska A; Furmanik F
    Przegl Lek; 2002; 59(7):502-8. PubMed ID: 12516238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma.
    Gordon B; Haire W; Kessinger A; Duggan M; Armitage J
    Bone Marrow Transplant; 1991 Dec; 8(6):497-502. PubMed ID: 1790430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Protein C, protein S and thrombomodulin: one of the natural antithrombotic mechanisms].
    Lobato-Mendizábal E; Ruiz-Argüelles GJ
    Rev Invest Clin; 1990; 42(1):54-62. PubMed ID: 2173090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.